Aqr Capital Management LLC Amylyx Pharmaceuticals, Inc. Transaction History
Aqr Capital Management LLC
- $64.6 Billion
- Q2 2024
A detailed history of Aqr Capital Management LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 3,340,943 shares of AMLX stock, worth $8.75 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,340,943
Previous 116,489
2768.03%
Holding current value
$8.75 Million
Previous $330,000
1823.33%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AMLX
# of Institutions
140Shares Held
44.6MCall Options Held
226KPut Options Held
909K-
Vanguard Group Inc Valley Forge, PA4.22MShares$11.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$6.99 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$6.84 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA1.9MShares$4.99 Million1.57% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL1.82MShares$4.78 Million0.02% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $153M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...